CQ Pharmaceutical Holding Co (SZSE:000950) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000950 CQ Pharmaceutical Holding Co Ltd SZSE:000950
79 GF Score
Price ¥5.34
GF Value ¥5.56
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is CQ Pharmaceutical Holding Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

CQ Pharmaceutical Holding Co Valuation Rank Related Terms

SZSE:000950
79GF Score
CQ Pharmaceutical Holding Co Ltd SZSE:000950
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?

Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued. The current stock price of ¥5.34 is trading 4% below its estimated GF Value™ of ¥5.56. GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.

Key valuation signals for SZSE:000950:

  • Valuation Rank:
  • GF Value™: ¥5.56 vs. price of ¥5.34 (4% below fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CQ Pharmaceutical Holding Co Business Description

Address 333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
79GF Score

Get the complete analysis for SZSE:000950

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.34
Price
¥5.56
GF Value